Conversely, enhancing basal autophagy through genetic manipulation or the use of Tat-Beclin 1 peptide to disrupt the HER2/Beclin 1 interaction and induce autophagy effectively inhibits HER2-driven tumor growth [95]. The gene discussed is ERBB2; the disease is neoplasm.